Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01864629
Other study ID # IRB_00061119
Secondary ID
Status Completed
Phase N/A
First received May 11, 2013
Last updated October 24, 2017
Start date April 2013
Est. completion date January 2016

Study information

Verified date October 2017
Source University of Utah
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effectiveness of focused family planning counseling on the uptake and continuation of highly effective contraceptive methods (defined as the intrauterine device, implant, and both male and female sterilization methods including vasectomy, tubal ligation and Essure) during the postpartum period in women who have recently experienced a preterm delivery.

The investigators hypothesize that women with a recent preterm birth (PTB) will be more likely to initiate and continue using a highly effective method of contraception when provided with focused family planning counseling.


Recruitment information / eligibility

Status Completed
Enrollment 134
Est. completion date January 2016
Est. primary completion date October 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 14 Years to 50 Years
Eligibility Inclusion Criteria:

- Women who deliver a premature infant that is between the gestational ages of 24 weeks 0 days and 36 weeks 6 days at our institution.

Exclusion Criteria:

- Women who have delivered via cesarean section and have also had a sterilization procedure at the time of the cesarean section.

Study Design


Intervention

Behavioral:
Focused contraception counseling
This intervention will be provided to those randomized to the intervention group only. This counseling will follow a pre-written, structured script describing all contraceptive methods in rank order starting with most effective to least effective in preventing unplanned pregnancy.

Locations

Country Name City State
United States University of Utah Hospital Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Use of highly effective method Three months
Secondary Pregnancy outcomes 12 months, 18 months, 24 months, 36 months
Secondary Use of highly effective method 12 months, 24 months, 36 months